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Dear Editor,
We would like to thank sincerely Balta et al. (1) for their
positive comments and kind interest concerning our original
research article that was recently published in Clinics (2). As
indicated in the authors’ comments, red cell distribution
width (RDW) is a measurement of the size variation in red
blood cells, as well as an index of the heterogeneity of the
circulating erythrocytes, which is commonly utilized in
the differential diagnosis of underlying anemia (3). More
recently, RDW has been shown to be a marker and
independent predictor of a variety of coronary artery
diseases, including unstable and stable clinical entities and
even microvascular disorder (4,5). However, it remains
unclear whether anisocytosis might be the cause or a simple
epiphenomenon on of the underlying disease (3). Apparently,
our published study provided a novel finding regarding the
role of RDW in predicting the presence of slow coronary flow.
We agree with authors’ comment on the potential impacts
of different pathophysiological backgrounds, such as
inflammatory status, on RDW (1). The data in our study
showed a positive correlation between RDW and plasma C-
reactive protein levels, which could be indirect evidence
that RDW is influenced by a variety of inflammatory
diseases.
In fact, a number of useful biomarkers for predicting the
future development of cardiovascular disease, as well as the
outcomes in patients with cardiovascular diseases, are
clinically available. However, future studies are needed to
evaluate whether these biomarkers are useful in patients
with slow coronary flow. We previously reported that the
plasma concentrations of CRP and interleukin-6 were higher
and were positively correlated with the thrombosis in
myocardial infarction frame count in patients (n = 36) with
slow coronary flow, compared with normal coronary flow
subjects (n = 20), suggesting that an inflammatory response
might be involved in the pathogenesis of slow coronary
flow (6).
With regard to the time that we used to measure the RDW
levels in our study, we appreciate the authors’ scientific
comments on our manuscript and agree with the authors’
point that delaying blood sampling can cause abnormal
results in RDW measurement (1). We determined the RDW
levels within one hour after the blood samples were
collected from all of the patients.
Finally, to the best of our knowledge, the mechanisms
involved in the manifestation of slow coronary flow appear
multifactorial and are not yet fully understood. Based on the
observations reported, we previously hypothesized that an
inflammatory process was involved in the development of
slow coronary flow (7). We are aware that RDW alone,
without any other inflammatory indicators, cannot provide
clinicians with sufficient information about the inflamma-
tory status and prognostic indications of patients with slow
coronary flow, as the authors indicated (1). Nevertheless,
RDW is an easy, inexpensive, and routinely reported test,
the assessment of which might allow for the acquisition of
significant diagnostic and prognostic information in
patients with cardiovascular disorders (3). Further detailed
evaluations are needed to build upon the findings reported
in our manuscript.
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